We report a case of leukemic involvement of cervical lymph nodes detected by 18F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT for evaluation of extramedullary disease. PET demonstrated marked tracer uptake in cervical lymph nodes.

Mar 22, 2013 · FDG PET/CT is a valuable imaging modality in diagnosis, therapy assessment, and prognosis of multiple myeloma. Multiple myeloma is the second most frequent blood malignancy after non-Hodgkin lymphoma and is the most common cause of …

Based on the ability of 18 F-FDG PET/CT to distinguish between metabolically active and inactive disease, this technique is now the preferred functional imaging modality to evaluate and to monitor the effect of therapy on myeloma-cell metabolism.

¹⁸F-FDG PET/CT is a valuable tool in the diagnosis, management, and monitoring of multiple myeloma, smouldering multiple myeloma, and solitary plasmacytoma. It can assess bone damage, detect extramedullary sites of clonal plasma cells, and provide prognostic information.

The International Myeloma Working Group consensus aimed to provide recommendations for the optimal use of ¹⁸fluorodeoxyglucose (¹⁸F-FDG) PET/CT in patients with multiple myeloma and other plasma cell disorders, including smouldering multiple myeloma and solitary plasmacytoma. …

We report a case of leukemic involvement of cervical lymph nodes detected by 18 F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT for evaluation of extramedullary disease.

18 F-fluorodeoxyglucose positron emission tomography integrated with computed tomography (18 F-FDG PET/CT) is an effective modality to assess disease burden, detect extra-medullary disease and monitor minimal residual disease (MRD) for multiple myeloma (MM) patients.

18 F-Fluorodeoxyglucose (FDG) PET has been used for staging of hematologic malignancies for years. In multiple myeloma, this imaging modality can be used in many different scenarios, including initial staging, evaluation of treatment response, and investigation of …

We provide updated guidance and standards for the indication, acquisition, and interpretation of [18 F]FDG PET/CT for plasma cell disorders. Procedures and characteristics are reported and different scenarios for the clinical use of [18 F]FDG PET/CT are discussed.

Oct 22, 2013 · We report a case of leukemic involvement of cervical lymph nodes detected by F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT...